Susquehanna Portfolio Strategies’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,482
Closed -$127K 1069
2025
Q4
$127K Buy
30,482
+11,457
+60% +$44.3K ﹤0.01% 974
2025
Q3
$62.6K Buy
+19,025
New +$53.7K ﹤0.01% 1020

Other funds holding PGEN

Susquehanna Portfolio Strategies's PGEN Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Precigen (PGEN) in Q1 2026, closing a stake of 30,482 shares — an estimated $127K sold.

Susquehanna Portfolio Strategies first reported a position in PGEN in Q3 2025 and held it in 2 quarters. The position peaked at $127K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 30,482 Precigen shares in Q1 2026, an estimated $127K.
  • Susquehanna Portfolio Strategies first reported a position in Precigen in Q3 2025 and held it in 2 quarters.
  • Susquehanna Portfolio Strategies's Precigen position peaked at $127K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.